Pragmatic screening for autoimmune‐associated epilepsy in drug‐resistant epilepsy of unknown etiology in resource‐limited settings: A hypothesis‐generating study
Epileptic Disorders · 08.10.2026
DOI: 10.1002/epd2.70439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epileptic Disorders, online erschienen am 08.10.2026. Verfasst von Tomásia O de H M Frezatti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences and Behaviour Sciences, Universidade de São Paulo, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribe…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the feasibility of investigating autoimmune etiology in adults with drug‐resistant epilepsy (DRE) of unknown origin in resource‐limited settings and to develop a pragmatic, hypothesis‐generating screening approach to guide autoantibody testing.
Methods
A prospective observational study including adults with DRE of unknown etiology was conducted at a tertiary epilepsy center in Brazil. All patients underwent standardized assessment including inflammatory and autoimmunity markers, brain magnetic resonance imaging (MRI), electroencephalography (EEG), cerebrospinal fluid (CSF) analysis, and application of the APE2 and ACES scores. Clinical, laboratory, and imaging findings were analyzed in the context of published autoimmune‐associated epilepsy (AAE) profiles to inform a pragmatic screening strategy.
Results
Twenty‐six patients (46.2% female; median epilepsy duration: 18.5 years) were included. EEG findings were nonspecific. Six patients developed mesial temporal abnormalities on follow‐up MRI. CSF protein elevation was observed in 37.5%, oligoclonal bands in 13.6%, and elevated IgG index in 18.2%. Antinuclear antibodies were detected in 26.9%. APE2 score ≥ 4 was present in 57.7%, while ACES score ≥ 2 occurred in 11.5%. Due to limited access to antibody testing, only one patient underwent CSF autoantibody analysis, confirming high‐titer anti‐GAD65. Based on integrated clinical, laboratory, and imaging findings, a pragmatic screening algorithm was proposed to prioritize candidates for autoantibody testing. Significance In resource‐limited settings, systematic use of accessible clinical and laboratory markers may help identify patients with higher pre‐test probability of AAE. A pragmatic screening approach may improve diagnostic efficiency and support individualized decision‐making when comprehensive antibody testing is not readily available.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosciences and Behaviour Sciences, Universidade de São Paulo, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil.
ORCID-Profile: Tomásia O de H M Frezatti, Ricardo L Saute, Veriano Alexandre Júnior, Frederico N Nakano, Marina T R P Dalio, Tonicarlo R Velasco, João P Leite, Antônio Carlos Dos Santos, Vanessa D Marques, Américo C Sakamoto
Zitieren
APA
Frezatti, T. O. H. M., Saute, R. L., Júnior, V. A., Nakano, F. N., Dalio, M. T. R. P., Velasco, T. R., Leite, J. P., Dos Santos, A. C., Marques, V. D., & Sakamoto, A. C. (2026). Pragmatic screening for autoimmune‐associated epilepsy in drug‐resistant epilepsy of unknown etiology in resource‐limited settings: A hypothesis‐generating study. Epileptic Disorders. https://doi.org/10.1002/epd2.70439
Vancouver
Frezatti TOHM, Saute RL, Júnior VA, Nakano FN, Dalio MTRP, Velasco TR, et al. Pragmatic screening for autoimmune‐associated epilepsy in drug‐resistant epilepsy of unknown etiology in resource‐limited settings: A hypothesis‐generating study. Epileptic Disorders. 2026. doi:10.1002/epd2.70439
BibTeX
@article{Frezatti2026,
author = {Frezatti, Tomásia O de H M and Saute, Ricardo L and Júnior, Veriano Alexandre and Nakano, Frederico N and Dalio, Marina T R P and Velasco, Tonicarlo R and Leite, João P and Dos Santos, Antônio Carlos and Marques, Vanessa D and Sakamoto, Américo C},
title = {Pragmatic screening for autoimmune‐associated epilepsy in drug‐resistant epilepsy of unknown etiology in resource‐limited settings: A hypothesis‐generating study},
journal = {Epileptic Disorders},
year = {2026},
doi = {10.1002/epd2.70439}
}
EUVIMED